THR 640-672 Type 2 Diabetes Therapies

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Diabetes & Glucose Metabolism-Clinical/Translational
Thursday, March 5, 2015: 1:00 PM-3:00 PM
Hall D-F, Diabetes (San Diego Convention Center)
**This session is NOT eligible for CME credit**


Grigorios Rombopoulos, MD1, Elena Panitti1, George S Vernikos1, Katopodis Panagiotis2 and Skoutas Dimitrios3, (1)Novartis Hellas S.A., Athens, Greece
(2)Clinic of Internal Medicine of Athens Medical Group, Peristeri Clinic, Athens, Greece
(3)Sarafianos Lysimachos General Clinic of Thessaloniki, Thessaloniki, Greece
Poster Board Number: THR-640
Byung-Wan Lee, MD, PhD1, Jae Hyeon Kim2, Se Eun Park3, Chang Hee Jung4, Seung-Hwan Lee5, Sunghwan Suh6, Woo Je Lee4, Younghwan Jang7, Sung-Ho Kim7 and Cheol-Young Park3, (1)Severance Hospital, University of Yonsei University College of Medicine, Seoul, South Korea
(2)Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea
(3)Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea
(4)Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
(5)Seoul St. Mary’s Hospital, The Catholic University of Korea School of Medicine, Seoul, South Korea
(6)Dong-A University Medical Center, Seoul, South Korea
(7)LG Life Sciences, Seoul, South Korea
Poster Board Number: THR-641
Andrew J Lewin, MD1, Ralph DeFronzo, MD2, Sanjay Patel, MB ChB3, Dacheng Liu, PhD4, Renee Kaste, PhD4, Hans-Juergen Woerle, MD5 and Uli C Broedl, MD5, (1)National Research Institute, Los Angeles, CA
(2)Univ of Texas Hlth Science Ctr, San Antonio, TX
(3)Boehringer Ingelheim Ltd., Bracknell, Berkshire, United Kingdom
(4)Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT
(5)Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
Poster Board Number: THR-642
Sanjay Patel, MB ChB1, Andrew J Lewin, MD2, Ralph DeFronzo, MD3, Dacheng Liu, PhD4, Renee Kaste, PhD4, Hans-Juergen Woerle, MD5 and Uli C Broedl, MD5, (1)Boehringer Ingelheim Ltd., Bracknell, Berkshire, United Kingdom
(2)National Research Institute, Los Angeles, CA
(3)Univ of Texas Hlth Science Ctr, San Antonio, TX
(4)Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT
(5)Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany
Poster Board Number: THR-643
Molly Corbett Carr, MD, GlaxoSmithKline, King of Prussia, PA, June Ye, PhD, GlaxoSmithKline, Research Triangle Park, NC and Jane E Reusch, MD, Endocrinology Section, Denver Veterans Administration Medical Center, Denver, CO
Poster Board Number: THR-644
Susan Johnson1, Michelle A Anderson, MD, MSc, FASGE2, Robert Enns, MD, FRCP3, Jason M Mallory, PhD4, Margaret Sowell5, Tim Wilson1 and Firas H AL-Kawas, MD6, (1)GlaxoSmithKline, Research Triangle Park, NC
(2)Department of Internal Medicine, University of Michigan Hospital and Health Systems, MI
(3)Division of Gastroenterology, Pacific Gastroenterology Associates; St Paul's Hospital, Canada
(4)GlaxoSmithKline, King of Prussia, PA
(5)GCSP SERM - Development US, GlaxoSmithKline, Collegeville, PA
(6)Johns Hopkins University; Sibley Memorial Hospital, Washington, DC
Poster Board Number: THR-645
Carol H Wysham, MD1, Denise Vieke2, Marion Vetter, MD3, Yaohua He, MD, PhD3, Nayyar Iqbal, MD3, Elise Hardy4, Anna Ryden5 and Julio Rosenstock, MD6, (1)University of Washington
(2)Mercury Street Medical, Butte, MT
(3)Bristol-Myers Squibb, Princeton, NJ
(4)AstraZeneca, Wilmington, DE
(5)AstraZeneca, Gothenburg, Sweden
(6)Dallas Diabetes and Endocrine Center at Medical City, Dallas, TX
Poster Board Number: THR-647
Maria Batool, MD1, Sarah Bellefeuille, Pharm D2, Melissa Atwood, Pharm D2, Thomas S Rector, PhD3 and Nacide G Ercan-Fang, MD1, (1)Department of Endocrinology, University of Minnesota Medical Center, Minneapolis, MN
(2)Minneapolis VA Health Care System
(3)Center for Chronic Disease Outcome and Research, Minneapolis VA Health Care System
Poster Board Number: THR-648
Sophia Y Ali, MD1, Aditya Mehta2, Nitesh D Kuhadiya, MD, MPH2, Husam Ghanim, PHD3, Antoine Makdissi, MD4, Manav Batra, MD5, Jeanne Hejna6, Ajay Chaudhuri, MBBS, MRCP2 and Paresh Dandona, MD, PHD, FRCP, FACP2, (1)Internal Medicine, University at Buffalo, Buffalo, NY
(2)Diabetes and Endocrinology Center of Western New York, Williamsville, NY
(3)Medicine, State University of New York at Buffalo, Buffalo, NY
(4)Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo, Buffalo, NY
(5)Endocrinology, University at Buffalo, Williamsville, NY
(6)Suny at Buffalo
Poster Board Number: THR-649
Alaaeldin Bashier, MRCP, FACE, ECNU, MSc Diabetes1, Azza Abdulaziz Bin Hussain, MRCP, ECNU, Arab Board2, Elamin Abdelgadir, MBBS, MRCP, PGD Endocrine2, Ahmed Altinay, MBBS3, Puja Murli Thadani, MBBS, MSc Diabetes4, Fatheya Fardallah Alawadi, MBBS, FRCP, FACE5 and Salah Abusnana, FRCP, PhD, CCST6, (1)Endocrine Division, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates
(2)Endocrine Division, Dubai Hospital, Dubai Health Authority
(3)G.Medicine, Dubai Hospital, Dubai Health Authority
(4)Dubai Hospital, Mumbai
(5)Endocrine Division, Dubai Hospital, Dubai Health Authority, Ash Shariqah, United Arab Emirates
(6)Rcdr Centre. Ajman, UAE.
Poster Board Number: THR-650
Kristine Santos de Luna1, Erick Sta. Rosa Mendoza, M.D.2 and Leilani Basa Mercado-Asis, MD, PhD, MPH2, (1)Section of Endocrinology Diabetes and Metabolism, University of Santo Tomas Hospital, Manila, Philippines
(2)Section of Endocrinology and Metabolism, Department of Medicine, University of Santo Tomas, Manila City, Philippines
Poster Board Number: THR-651
Bruno Guerci, MD, PhD1, David A D'Alessio, MD2, Carol H Wysham, MD3, Nan Jia, PhD4 and Fady T Botros, PhD4, (1)Maladies Metaboliques & Nutrition, Hôpital Brabois Adultes
(2)Medicine, Division of Endocrinlogy, Metabolism & Nutrition, Duke University, Durham, NC
(3)Rockwood Center for Diabetes and Endocrinology, Spokane, WA
(4)Lilly Diabetes, Eli Lilly and Company
Poster Board Number: THR-652
Jaime A Davidson1, Guntram Schernthaner2, Laura Hieronymus3, Holly Jodon4, Ujjwala Vijapurkar5, Gary Meininger5 and William Canovatchel, MD6, (1)Touchstone Diabetes Center, The University of Texas Southwestern Medical Center, Dallas, TX
(2)Rudolfstiftung Hospital-Vienna, Vienna, Austria
(3)DiabetesCare and Communications, Lexington, KY
(4)Metabolic Disease Associates, Erie, PA
(5)Janssen Research & Development, LLC, Raritan, NJ
(6)Global Medical Affairs, Janssen Research & Development, LLC, Raritan, NJ
Poster Board Number: THR-653
Farid Saad, DVM, PhD, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany, Gheorghe Doros, PhD, Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA, Abdulmaged M Traish, PhD, Dept of Biochemistry & Urology, Boston University School of Medicine, Boston, MA and Aksam A Yassin, MD, PhD, Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany
Poster Board Number: THR-654
Farid Saad, DVM, PhD, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany and Aksam A Yassin, MD, PhD, Institute of Urology and Andrology, Segeberger Kliniken, Norderstedt, Germany
Poster Board Number: THR-655
Natalya Volkova, MD, PhD, Department of Internal Medicine, The Rostov State Medical University, Rostov-on-Don, Russia, Ilia Davidenko, Department of Internal Medicine #3, Rostov State Medical University, Rostov-on-Don, Russia, Maria Antonenko, MD, Internal Disease #3, Rostov State Medical University, Rostov-on-don, Russia, Igor Reshetnikov, Internal Medicine, Rostov State Medical University, Rostov-on-Don, Russia, Aida Gulmagomedova, Internal Disease 3, Rostov State Medical University, Rostov on Don, Russia, Irina Dzherieva, MD, PhD, Department of Internal medicine, Rostov State Medical University, Rostov on Don, Russia and Julia Rudakova, Rostov State Medical University, Rostov-on-Don, Russia
Poster Board Number: THR-656
Charlene Ann Vicencio Balili, Medicine, University of Santo Tomas Hospital, Manila, Philippines, Erick Sta. Rosa Mendoza, M.D., Section of Endocrinology and Metabolism, Department of Medicine, University of Santo Tomas, Manila City, Philippines and Leilani Basa Mercado-Asis, MD, PhD, MPH, Department of Medicine, Section of Endocrinology and Metabolism, University of Santo Tomas, Manila, Philippines
Poster Board Number: THR-659
Luigi Meneghini1, Ildiko Lingvay1, Jason Chao2, Andreas Stuhr3, Mahmood Kazemi3 and Mehul Dalal3, (1)University of Texas Southwestern Medical Center, Dallas, TX
(2)Xinyi, Inc., Bridgewater, NJ
(3)Sanofi US, Inc., Bridgewater, NJ
Poster Board Number: THR-660
Amy Kraus1, George Serbedzija1, Praveen Dhankhar2, Taisia Isupov2, Alexander Brun2 and Iftekhar Kalsekar3, (1)1T1D Exchange, Boston, MA
(2)AstraZeneca, Fort Washington, PA
(3)AstraZeneca, Fort Washington
Poster Board Number: THR-663
Benjamin Udoka Nwosu Sr.1, Louise Maranda2 and Mary Min-Chin Lee1, (1)Pediatrics, University of Massachusetts Medical School, Worcester, MA
(2)Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA
Poster Board Number: THR-664
Anne E Bunner, PhD1, Cameron L Wells, RD1, Elham Bayat, MD2 and Neal D Barnard, MD3, (1)Physicians Committee for Responsible Medicine, Washington, DC
(2)George Washington Medical Faculty Associates, Washington, DC
(3)George Washington University School of Medicine, Washington, DC
Poster Board Number: THR-665
JongHwa Kim and Su Jin Jeong, Endocrinology and metabolism, General Hospital, Bucheon, South Korea
Poster Board Number: THR-666
Grigorios Rombopoulos, MD1, Elena Panitti1, George S Vernikos1, Christos Katsinas2, Ioannis Stefanidis3 and Dimitrios Goumenos4, (1)Novartis Hellas S.A., Athens, Greece
(2)General Hospital of Ptolemaida "Mpodosakeio", Hemodialysis Unit
(3)University Hospital of Larissa, Clinic of Nephrology
(4)University Hospital of Patras, Clinic of Nephrology
Poster Board Number: THR-667
Zachary M Novakovic, B.S., Lake Erie College of Osteopathic Medicine, Erie, PA, Brian M Anderson, B.S., Medicine, Albany Medical College, Albany, NY and Patricia Grasso, PhD, Dept of Medicine/Division of Endocrinology and Metabolism, Albany Medical College, Albany, NY
Poster Board Number: THR-668
Jean Lin Chan1, Joy Koda2, Joseph Heilig3, Elaine Cochran, CRNP4, Phillip Gorden, M.D.4, Elif Arioglu Oral, MD5 and Rebecca J. Brown, M.D.6, (1)Bristol-Myers Squibb, San Diego, CA
(2)Bristol-Myers Squibb, San Diego
(3)AstraZeneca
(4)NIDDK, NIH, Bethesda, MD
(5)Dept Int Med/Endo Metab & Diab, Univ of Michigan, Ann Arbor, MI
(6)National Institutes of Health, Rockville, MD
Poster Board Number: THR-670
Anthony Emeka Ojieh, MBBS, MSc, Physiology, Delta State University, Abraka Delta State, Nigeria, Eseroghene Cecilia Adegor, Physiology, Delta State University, Abraka, Nigeria, Anthony Chukunweike Okolo, MBBS, MSc, Surgery & Cancer, Imperial College London, London, United Kingdom, Lawrence Oberhiri Ewhre, Pharmacology and Therapeutics, Delta State University, Abraka, Nigeria and Innocent Onyesom, Biochemistry, Delta State University, Abraka, Nigeria
Poster Board Number: THR-671
Mustafa Unubol1, Fatih Firat2, Basak Karasu3, Ali Akbas4, Velid Unsal4, Fikret Erdemir5, Volkan Yazak6, Bilal Acar7 and Imran kurt Omurlu8, (1)Tokat State Hospital, Clinic for Endocrine and Metabolic Disorders, Turkey
(2)Tokat State Hospital, Urology Department
(3)Turhal State Hospital, Pathology Department, Turkey
(4)Gazi Osman Paşa Faculty of Medicine, Clinical Biochemistry Department, Turkey
(5)Gazi Osman Paşa Faculty of Medicine, Urology Department, Turkey
(6)Nazilli State Hospital, Internal Medicine Department, Turkey
(7)Cankiri State Hospital, Internal Medicine, Turkey
(8)Adnan Menderes University, Medical Faculty, Department of Biostatistics, Turkey
Poster Board Number: THR-672
Eric G. Vajda, Ph.D., Preclinical Research and Develop, Ligand Pharmaceuticals Inc, La Jolla, CA, Diane J. Plotkin, Ph.D., Diane Plotkin Clinical Development Consultation Services, Poway, CA, Douglas K. Logan, M.D., Medpace Clinical Pharmacology Unit, Medpace, Inc., Cincinatti, OH, Yong-Xi Li, Ph.D., Medpace Bioanalytical Labs, Medpace, Inc., Cincinatti, OH, David G Orloff, M.D., Medical and Regulatory Affairs, Medpace, Inc., Cincinnati, OH, J. D. Pipkin, Ph.D., New Product Development, Ligand Pharmaceuticals Incorporated, San Diego, CA, Lin Zhi, Ph.D., Chemistry and Pharm Sciences, Ligand Pharmaceuticals Incorporated, La Jolla, CA and Keith B. Marschke, Ph.D., Ligand Pharmaceuticals Incorporated, La Jolla, CA
Poster Board Number: THR-669
Cecilia C. Low Wang, MD, Medicine / Endocrinology, Metabolism and Diabetes, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, Rebecca Sanagorski, NP, Endocrine Section, Denver VA Medical Center, Denver, CO, R Matthew Hawkins, PA-C, Medicine/Endocrinology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, CO, Joanna Gibbs, PA-C, Medicine/Endocrinology, Univ of Colorado AMC School of Medicine, Aurora, CO, Kenneth Tompkins, MD, Medicine, Univ of Colorado AMC School of Medicine, Mark Bridenstine, MD, Medicine/Endocrinology, Univ Colorado AMC School of Medicine, Aurora, CO, Stacey Seggelke, CNS, BC-ADM, Medicine/Endocrinology, Univ Colorado AMC School of Medicine and Boris Draznin, MD, PhD, Medicine, University of Colorado School of Medicine, Aurora, CO
Poster Board Number: THR-662
Robert C Hood, MD, FRCPC, FACE1, Richard F Arakaki, MD2, Carol H Wysham, MD3, Ying Grace Li4, Julie A Settles5 and Jeffrey A Jackson5, (1)Endocrine Clinic of Southeast Texas, Beaumont, TX
(2)University of Hawaii at Manoa, Honolulu, HI
(3)Rockwood Center for Diabetes and Endocrinology, Spokane, WA
(4)Eli Lilly and Company, Indianapolis, IN
(5)Lilly USA, LLC, Indianapolis, IN
Poster Board Number: THR-658
Michael Grimes, MD1, Peter L Perreiah, MS1, Laura Potoski, PharmD2, Denise Plis, B.A.B.A.3 and R Harsha Rao, MD, FRCP1, (1)Division of Endocrinology, VA Pittsburgh Healthcare System, Pittsburgh, PA
(2)Pharmacy Service Line, VA Pittsburgh Healthcare System, Pittsburgh, PA
(3)Information Resources- VISN4, VA Healthcare Network, Wilkes-Barre, PA
Poster Board Number: THR-657